Evaluation of HGV viremia prevalence and its co-infection with HBV, HCV, HIV and HTLV-1 in hemophilic patients of southern khorassan, iran

Hepatitis Monthly

Volumn 7, Issue 1, 2007, Pages 11-14

  Ziaee, Masood ^a   Zarban, Asghar ^a   Malekinejad, Peyman ^a   Akhbary, Hadi ^a  

^a BIRJAND UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 13; BLOOD CLOTTING FACTOR 5; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C VIRUS ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; HUMAN T CELL LEUKEMIA VIRUS ANTIBODY; UNCLASSIFIED DRUG; VIRUS ANTIBODY;

ADULT; AGE; ARTICLE; CORRELATIONAL STUDY; DISEASE SEVERITY; DISEASE TRANSMISSION; ENZYME LINKED IMMUNOSORBENT ASSAY; GENOTYPING TECHNIQUE; HEMOPHILIA; HEMOPHILIA A; HEMOPHILIA B; HEPATITIS B VIRUS; HEPATITIS G VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1; IMMUNOBLOTTING; MAJOR CLINICAL STUDY; MIXED INFECTION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEROPREVALENCE; VIREMIA; VIRUS IDENTIFICATION; VIRUS LOAD; VIRUS TRANSMISSION; VON WILLEBRAND DISEASE; YOUNG ADULT;

EID: 70350787580     PISSN: 1735143X     EISSN: 17353408     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Tucker TJ, Smuts HE. GBV-C/HGV genotypes: proposed nomenclature for genotypes 1. J Med Virol 2000; 62: 82-3.
2. Tucker TJ, Smuts HE, Eickhaus P. Molecular characterization of the 5´ non-coding region of South African GBV-C/HGV isolates: major deletion and evidence for a fourth genotype. J Med Virol 1999; 59: 52-9.
3. Katayama K, Kageyama T, Hoshino F. Full-length GBVC/HGV genomes from nine Japanese isolates: characterization by comparative analyses. Arch Virol 1998; 143: 1063-75.
4. Roth WK, Waschk D, Marx S, Tschauder S, Zeuzem S, Bialleck H, et al. Prevalence of hepatitis G virus and its strain variant, the GB agent, in blood donations and their transmission to recipients. Transfusion 1997; 37: 651-5.
5. Wejstal R, Manson AS, Widell A. Perinatal transmission of hepatitis G virus (GB virus type C) and hepatitis C virus infections-a comparison. Clin Infect Dis 1998; 28: 816-21.
6. Stark K, Doering CD, Bienzele U. Risk and clearance of GB virus C/hepatitis G virus infection in homosexual men: a longitudinal study. J Med Virol 1999; 59: 303-6.
7. Komatsu H, Fujisawa T, Inui A. GBV-C/HGV infection in children with chronic hepatitis C. J Med Virol 1999; 59: 154-9.
8. Lampe E, de Oliveira JM, Pereira JL, Saback FL, Yoshida CF, Niel C. Hepatitis G virus (GBV-C) infection among Brazilian patients with chronic liver disease and blood donors. Clin Diagn Virol 1998; 9: 1-7.
9. Khudyakov YE, Cong ME, Bonafonte MT, Abdulmalek S, Nichols BL, Lambert S, et al. Sequence variation within a nonstructural region of the hepatitis G virus genome. J Virol 1997; 71: 6875-80.
10. Kalkan A, Ozdarendelil A, Bulutl Y. Prevalence and genotypic distribution of hepatitis GB-C/HG and TT viruses in blood donors, mentally retarded children and four groups of patients in eastern Anatolia, Turkey. Jpn J Infect Dis 2005; 58: 222-7.
11. Eveline P, Bunschoten M, Damen M. Hepatitis G virus RNA and hepatitis G virus-E2 antibodies in Dutch Hemophilia Patients in Relation to Transfusion History. Blood 1998; 92: 2164-8.
12. Alonso E, Gerber M, Friedman P. Hepatitis G virus in clotting factor concentrates. Hemophilia 2003; 9: 110-5.
13. Bagheri Lankarani K. Acute Hepatitis C Infection. Hep Mon 2004; 4: 43-8.
14. Abu Odeh RO, Al-Moslih MI, Al-Jokhdar MW, Ezzeddine SA. Detection and genotyping of GBV-C virus in the United Arab Emirates. J Med Virol 2005; 76: 534-40.
15. Hanley J, Jarvis L. Patterns of hepatitis G viremia and liver disease in hemophiliacs previously exposed to non virus inactivated coagulation factor concentrates. Thromb Haemost 1998; 79: 291-5.
16. Yamada O, Sumazaki R, Kajiwara Y. Natural course of HGV infection in haemophiliacs. Br J Haematol 1998; 102: 616-21.
17. Kaya S, Cicioglu Aridogan B, Demirci M. The prevalence of hepatitis G virus in patients with hepatitis B and C virus infections. Mikrobiyol Bul 2004; 38: 421-7.
18. Filippi F, Colombo M, Rumi M. High Rates of Hepatitis G Virus Infection in multi transfused patients with hemophilia. Blood 1997; 90: 4634-7.
19. Kupfer B, Ruf T, Matz B, Nattermann J. Comparison of GB virus C, HIV, and HCV infection markers in hemophiliacs exposed to non-inactivated or inactivated factor concentrates. J Clin Virol 2005; 34: 42-7.
20. Massud I, Corti M, de Tezanos Pinto M, Perez Bianco R, Picchio G, Bare P. Prevalence of hepatitis G virus infection in a cohort of hemophilic HIV positive patients (in Spanish). Medicina (B Aires) 2002; 62: 173-5.
21. Novikov DV, Pimenov VK, Samokhvalov EI, Mokhonov VV, Kolobov AA, Kopnina EO, et al. Determination of hepatitis G virus markers in various risk groups. Vopr Virusol 2000; 45: 20-2.
22. Amini S, Andalibi Mahmoodabadi S, Lamian S, Joulaie M, Mahmoodi Farahani M. Prevalence of Hepatitis G virus (HGV) in High-Risk Groups and Blood Donors in Tehran, Iran. Iranian J Publ Health 2005; 34: 41-6.
23. Chakrabarti S, Pradhan P, Roy A, Hira M, Bandyopadhyay G, Bhattacharya DK. Prevalence of anti HCV, HBsAg and HIV antibodies in high risk recipients of blood and blood products. Indian J Public Health 2006; 50: 43-4.
24. Alavian SM, Ardeshiri A, Hajarizadeh B. Seroprevalence of Anti-HCV antibodies among Iranian hemophiliac patients. Transfusion Today 2001; 49: 4-5.
25. Barusruk S, Urwijitaroon Y. High prevalence of HGV co-infection with HBV or HCV among northeastern Thai blood donors March 2006. Available from:ww.tm.mahidol. ac.th/en/seameo/Vol37No2Mar2006/08-3676.pdf.